Aquestive Therapeutics, Inc. AQST Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net
Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s accounts receivable allowances and accruals - trade and other receivables, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s accounts receivable allowances and accruals - trade and other receivables, net?
- Aquestive Therapeutics, Inc. (AQST) reported accounts receivable allowances and accruals - trade and other receivables, net of $0 in Q1 2026.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s accounts receivable allowances and accruals - trade and other receivables, net?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s accounts receivable allowances and accruals - trade and other receivables, net has grown at a 6.9% compound annual growth rate (CAGR), from $416K to $582K.
- What does accounts receivable allowances and accruals - trade and other receivables, net mean?
- This represents the net value of trade and other receivables after accounting for all applicable allowances, accruals, and reserves for uncollectible amounts. It provides a realistic estimate of the cash the company expects to collect from its outstanding invoices. Investors use this to assess the quality of receivables and the effectiveness of the company's credit management policies.